glp-1 type 1 diabetes In patients with residual ß-cell function, treatment Ozempic and Other Off-Label Drugs

Similar content being viewed by others Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are structurally modified analogs of endogenous GLP-1, engineered to resist enzymatic degradation while retaining potent agonism at the GLP-1 receptor (GLP-1R) 1

Note injection dates, doses, ketone readings, weight, any side effects, and dietary adherence in one place

They also lead to a reduction in waist circumference by 4.97 cm (nearly 2 inches), which is a significant improvement over metformin

Reported semaglutide overdose adverse events include gastrointestinal effects (e.g., nausea, vomiting, abdominal pain), fainting, headache, migraine, dehydration, acute pancreatitis and gallstones